← Back to signals
ZBH
BUYZimmer Biomet Holdings Inc.
Health Care
0.82
PEGY ratio
Rank #125
Why This Matters
This stock appears undervalued relative to its growth and dividend yield. Strong projected growth of 133.3% annually over 5 years. Pays a 1.2% dividend yield.
ZBH trades at 21.5x earnings against 25.0% capped growth (actual 133.3%) + 1.2% yield (PEGY 0.82). Valuation looks favorable — the price is not fully reflecting the growth and yield on offer.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 133.3%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-06-02
Valuation
21.5x
P/E Ratio
Growth
133.3%
5yr EPS
Income
1.2%
Div Yield
PEGY Components
PEGY Score0.82
Denominator26.2%
EPS (TTM)$3.86
Market Data
Price$82.94
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.85→0.82(-0.03)
Rank
#130→#125(+5 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only